Overview
At Crestview Biotech Innovations, we are passionate about transforming the lives of patients with rare diseases through innovative therapies. Our team has made significant strides in developing a groundbreaking biologic product aimed at treating a specific rare genetic disorder that currently has limited treatment options. After successfully completing our preclinical trials, we have demonstrated promising efficacy and safety results that position us for the next stage of development. To date, we have secured initial funding of $500,000 which has allowed us to build our foundational research framework and initiate early-stage trials. With this investment, we have established partnerships with leading research institutions and gained valuable insights into patient needs and clinical pathways. Our traction includes a signed agreement with a prestigious university for collaboration on further studies and a growing interest from potential pharmaceutical partners. We are now seeking $240,000 to scale our operations and expedite the development of our promising therapy. This funding will be crucial in transitioning us from preclinical development into clinical trials, allowing us to cond…
Use of funds
The requested $240,000 will be allocated as follows:
- Clinical Trial Preparations: $120,000 for further preclinical studies and regulatory compliance to prepare for human trials.
- Laboratory Expansion: $60,000 to improve our lab facilities and procure advanced equipment necessary for product refinement.
- Intellectual Property Protection: $30,000 for filing patents and protecting our innovations.
- Operational Costs: $30,000 to support staff and operational expenses during this critical growth phase.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.